Becton, Dickinson and Company BDXB NYSE

NYSE • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score

64/100

3/7 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

Becton, Dickinson and Company (BDXB) 的分析師一致評級為 Buy, 基於 30 位分析師追蹤該股票. 其中, 16 建議買入, 13 建議持有, and 1 建議賣出.

分析師共識 — BDXB

Buy

強力買入

買入

持有

賣出

強力賣出

30 analysts

價格目標

暫無價格目標數據。

其他人也在看

BSX-PA

Boston Scientific Corporation

$122.18

+2.37%

BHFAP

Brighthouse Financial, Inc.

$16.43

+1.23%

BHFAO

Brighthouse Financial, Inc.

$16.98

+1.49%

BHFAN

Brighthouse Financial, Inc.

$13.39

+0.45%

AEPPZ

American Electric Power Company, Inc.

$47.12

-1.09%

LLY

Eli Lilly and Company

Becton, Dickinson and Company BDXB NYSE

分析師共識 — BDXB

其他人也在看

獲取低估股票提醒